STATE STREET CORP

Position in INBX — Inhibrx Biosciences, Inc.

CIK 93751 BOSTON, MA

Position in INBX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$60,683,395

+$23,650,086 QoQ

Shares Held

640,458

+16.3% QoQ

Ownership

4.35%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 161 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 8% Shared 0% None 92%

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,552,510,511 across 411 Biotechnology names. INBX ranks #106 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	11,871,459	$5,896,909,829
2	REGN	Regeneron Pharmaceuticals, Inc.	4,834,688	$3,014,621,355
3	INCY	Incyte Corp	9,722,336	$1,102,124,008
4	MRNA	Moderna, Inc.	15,726,193	$1,101,305,295
5	ALNY	Alnylam Pharmaceuticals, Inc.	3,555,689	$1,070,369,059
6	RVMD	Revolution Medicines, Inc.	4,897,051	$917,119,711
7	RPRX	Royalty Pharma plc	12,338,229	$691,804,500
8	INSM	INSMED Inc	6,052,174	$645,282,791

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$60,683,395	640,458	+16.3%	Shares	Defined	2026-08-07
2026-03-31	$37,033,309	550,845	+46.9%	Shares	Defined	2026-05-15
2025-12-31	$29,621,919	374,961	+83.9%	Shares	Defined	2026-02-13
2025-09-30	$6,868,126	203,923	-0.5%	Shares	Defined	2025-11-14
2025-06-30	$2,924,764	204,959	+18.5%	Shares	Defined	2025-08-14
2025-03-31	$2,418,926	172,904	-2.0%	Shares	Defined	2025-05-15
2024-12-31	$2,716,205	176,377	+10.1%	Shares	Defined	2025-02-14
2024-09-30	$2,508,403	160,179	+7.8%	Shares	Defined	2024-11-14
2024-06-30	$2,105,463	148,586	—	Shares	Defined	2024-08-14
No filing history on record for this holder in this stock.